Abstract Chiral polychlorinated biphenyl (PCB) congeners, such as PCB 136, are atropselectively metabolized to various hydroxylated PCB metabolites (HO-PCBs). The present study investigates the effect of two thiol antioxidants, glutathione and N-acetyl-cysteine (NAC), on profiles and chiral signatures of PCB 136 and its HO-PCB metabolites in rat liver microsomal incubations. Liver microsomes prepared from rats pretreated with phenobarbital were incubated with PCB 136 (5 μM) in the presence of the respective antioxidant (0-10 mM), and levels and chiral signatures of PCB 136 and its HO-PCB metabolites were determined. Three metabolites, 5-136 (2,2′,3,3′,6,6′-hexachlorobiphenyl-5-ol), 4-136 (2,2′,3,3′, 6,6′-hexachlorobiphenyl-4-ol), and 4,5-136 (2,2′,3,3′,6,6′-hexachlorobiphenyl-4,5-diol), were detected in all incubations, with 5-136 being the major metabolite. Compared to microsomal incubations without antioxidant, levels of 4,5-136 increased with increasing antioxidant concentration, whereas levels of PCB 136 and both mono-HO-PCBs were not affected by the presence of either antioxidant. PCB 136, 4-136, and 5-136 displayed significant atropisomeric enrichment; however, the direction and extent of the atropisomeric enrichment was not altered in the presence of an antioxidant. Because 4,5-136 can either be conjugated to a sulfate or glucuronide metabolite that is readily excreted or further oxidized a potentially toxic PCB 136 quinone, the effect of both thiol antioxidants on 4,5-136 formation suggests that disruptions of glutathione homeostasis may alter the balance between both metabolic pathways and, thus, PCB 136 toxicity in vivo.
Introduction
Historic uses of PCBs, for example as coolants, lubricants, and dielectric fluid, have resulted in widespread environmental contamination and continue to contribute to human PCB exposures via dietary sources, especially contaminated fish (Kostyniak et al. 2005; Schecter et al. 2010) . PCBs were also used in building materials, for example as light ballasts and caulking, and are major sources of current PCB contamination in older buildings. Recent studies demonstrate that PCBs are formed inadvertently by industrial processes and are contaminants in indoor paint (Anezaki and Nakano 2013; Hu and Hornbuckle 2010) , thus contributing to indoor air contamination of old and new buildings, including schools (Thomas et al. 2012) . PCB congeners with multiple ortho chlorine substituents represent a particular concern because of their prevalence in susceptible populations, such as school children (Megson et al. 2013) or individuals with genetic risk factors for neurodevelopmental disorders (Mitchell et al. 2012) . Moreover, human epidemiological data and laboratory studies suggest a negative association between developmental exposure to environmental PCBs and measures of neurophysiological function in infancy and childhood (Mariussen and Fonnum 2006) . Taken together, these studies demonstrate that PCBs remain a current and significant human health risk.
Several neurotoxic PCB congeners with three or four ortho substituents and their HO-PCB metabolites are chiral because they exist as stable rotational isomers, or atropisomers, that are nonsuperimposable mirror images of each other (Lehmler et al. 2010) . Chiral PCB congeners are atropselectively oxidized to HO-PCBs by P450 enzymes, thus resulting in atropisomerically enriched PCBs and HO-PCBs (Kania-Korwel et al. 2012; Kania-Korwel and Lehmler 2015b; Lu et al. 2013; Wu et al. 2011 Wu et al. , 2013a Wu et al. , 2014 . The oxidation of PCBs to HO-PCBs can occur via a reactive PCB epoxide (Forgue and Allen 1982; Forgue et al. 1979 ) that subsequently rearranges to an HO-PCB or reacts with cellular nucleophiles (e.g., glutathione). Alternatively, HO-PCBs can be formed by direct insertion of an oxygen atom into an aromatic C-H bond (Preston et al. 1983) . HO-PCB metabolites can be conjugated to form glucuronide (Sacco and James 2004; Tampal et al. 2002) or sulfate metabolites (Dhakal et al. 2012; Liu et al. 2006; Sacco and James 2005) . Alternatively, HOPCBs can be further metabolized by P450 enzymes to dihydroxy and, subsequently, quinone metabolites (Amaro et al. 1996) . The quinone metabolites can react with proteins or other cellular nucleophiles, such as thiol antioxidants, and are thought to play an important role in the toxicity of PCBs (Grimm et al. 2015) . It is likely that metabolism steps involving the reaction of reactive PCB metabolites are atropselective and, thus, affect metabolite profiles and chiral signatures of PCB metabolites, including HO-PCBs; however, the stereoselectivity of the oxidation of PCBs in the presence of antioxidants or cellular nucleophiles has not been investigated to date.
Several studies have reported that some PCBs and their metabolites alter cellular glutathione homeostasis, and that NAC co-treatment can attenuate adverse effects in cells in culture and in vivo following PCB exposure (Lai et al. 2010; Slim et al. 2000; Srinivasan et al. 2001; Zhu et al. 2013 ). The present study examines if the presence of both thiol antioxidants in microsomal incubations affects HO-PCB metabolite profiles and chiral signatures of HO-PCB metabolites. A microsomal formulation prepared from rats pretreated with phenobarbital (Wu et al. 2011 ), a classical inducer of CYP2B enzymes, was used because chiral PCBs are metabolized by CYP2B enzymes (Lu et al. 2013; Warner et al. 2009 ) to RyRactive meta hydroxylated metabolites (Niknam et al. 2013) . PCB 136 was selected for this exploratory study because of its environmental relevance (Kania-Korwel and Lehmler 2015a; Lehmler et al. 2010) , its wellinvestigated in vitro and in vivo metabolism (Birnbaum 1983; Schnellmann et al. 1983; Wu et al. 2011 Wu et al. , 2013a Wu et al. , 2014 , and its effect on cellular targets implicated in PCB developmental neurotoxicity (Pessah et al. 2009; Yang et al. 2014 ). Chemicals and reagents PCB 136; 2, 2′, 3, 3′, 6, ; 2,2′, 3,3′,6,6′-hexachlorobiphenyl-5-ol (5-136); 4,5-dimethoxy-2, 2′,3,3′,6,6′-hexachlorobiphenyl (methylated derivative of 2, 2′, 3,3′,6,6′-hexachlorobiphenyl-4,5-diol; 4,5-136) ; and 2,2′, 3′,4,6,6′-hexachloro-3-methoxybiphenyl (methylated derivative of 2,2′,3′,4,6,6′-hexachlorobiphenyl-3-ol; 3-150) were synthesized as described previously (Waller et al. 1999) . The chemical structures and the abbreviations of the HO-PCB metabolites are shown in Fig. 1a . Surrogate recovery standards (2, 3, 4′, 5, PCB 117; 2′, 3, 3′, 4, 5, and internal standard (2, 2′, 3, 4, 4′, 5, 6, PCB 204) were purchased from Accustandard (New Haven, CT). NAC and tetrabutylammonium sulfite were purchased from Fisher Scientific (Pittsburg, PA, USA). L-Glutathione and β-nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate (NADPH) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Pesticide grade n-hexane, 2-propanol and methyl tert-butyl ether (MTBE) were purchased from Fisher Scientific (Pittsburg, PA, USA).
Materials and methods

Animal treatment and microsome preparation
The preparation and characterization of the microsomes used in this study has been described previously (Wu et al. 2011) . In short, microsomes were prepared by differential centrifugation from 8-week-old male Sprague-Dawley rats (Harlan, Inc., Indianapolis, IN, USA) pretreated with intraperitoneal injections of phenobarbital (102 mg/kg b.w./day) in saline for three consecutive days. Aliquots of the microsomes were stored at −80°C. 7-Ethoxyresorufin-O-deethylase (CYP1A), benzyloxyresorufin-O-debenzylase (CYP2B) and 7-benzyloxyquinoline debenzylation (CYP3A) activities have been reported previously and were 4-, 100-, and 2-fold higher compared to activities of control microsomes from saline pretreated animals (Wu et al. 2011 ).
Microsomal incubations with PCB 136 in the presence of antioxidants
Incubation mixtures consisted of 0.1 M phosphate buffer (pH=7.4), 3 mM magnesium chloride, 0.5 mg/mL microsomal protein, 0.5 mM NADPH (Wu et al. 2011 ) and various concentrations of glutathione (0 to 10 mM) or NAC (0 to 10 mM). These antioxidant concentrations were selected based on an earlier metabolism study with hexachlorobenzene (van Ommen et al. 1986 ). Mixtures were preincubated for 5 min at 37°C in a shaking water bath. A solution of PCB 136 in DMSO (10 μL) was added to give a concentration of 5 μM PCB 136 in a final volume of 2 mL. Earlier studies demonstrated that a considerable percentage of PCB 136 is oxidized to HO-PCBs at this PCB 136 concentration, thus allowing the simultaneous determination of chiral signatures for the parent PCB and its HO-PCB metabolites (Wu et al. 2011) . The incubations were continued at 37°C for 5 min and stopped by adding 0.5 N NaOH (2 mL), followed by heating each sample at 90°C for 10 min. Incubations were performed in triplicate for each concentration of glutathione or NAC. Control incubations were performed in parallel and included: (1) blank incubations and incubations without PCB 136 to determine background contamination with OH-PCBs and their methylated derivatives, and (2) incubations without NADPH, without microsomes or with heat inactivated microsomes to control for any abiotic transformation of PCB 136. No metabolites were observed in these control samples.
Extraction and separation of PCB 136 and its hydroxylated metabolites
The extraction of PCB 136 and its hydroxylated metabolites was performed following a published method without separation of PCB 136 from its metabolites (Wu et al. 2011) . Briefly, surrogate recovery standards (PCB 117, 500 ng; 4-159, 274 ng) were added to each sample after heat inactivation. Solvent blanks were extracted in parallel. The samples were acidified with 6 M HCl (1 mL) and extracted with 2-propanol (3 mL) and hexane-MTBE (5 mL, 1:1, v/v). The top organic layer was transferred to a different vial, and the aqueous layer was washed with hexane (3 mL). The combined organic layer was washed with aqueous KCl (1 %, 3 mL). The KCl phase was reextracted with hexane (3 mL), and the combined organic phases were concentrated to~1 mL under a gentle stream of nitrogen. Five drops of methanol were added to each sample, and the hydroxylated metabolites were derivatized with diazomethane in diethyl ether (0.5 mL) as described earlier (Wu et al. 2011) . The samples were subjected to a sulfur cleanup step, followed by treatment with concentrated sulfuric acid using a published method (Kania-Korwel et al. 2007 ). The internal standard PCB 204 (200 ng) was added to each sample before the gas chromatographic analysis.
Gas chromatographic determinations
The analysis of PCB 136 and the HO-PCB metabolites (as the corresponding methylated derivatives) has been described elsewhere (Wu et al. 2011) . All analyses employed an Agilent 7890A gas chromatograph equipped with a 63 Ni-μECD detector. The total amounts of PCB 136 and metabolites were initially determined on a DB-1 MS capillary column (60 m×0.25 mm ID×0.25 μm film thickness; Agilent, Santa Clara, CA, USA) without separation of atropisomers. The injector and detector temperatures were 280 and 300°C, respectively. The temperature program was as follows: 100°C for 1 min, 5°C/min to 250°C, hold for 20 min, 5°C/min to 280°C, and hold for 3 min. The flow rate of the carrier gas (helium) was 3 mL/min. Levels of PCB 136 and its HO-PCB metabolites were calculated using PCB 204 as internal standard and were not adjusted for the recovery of the surrogate recovery standards. (Haglund and Wiberg 1996) . E 1 -5-136 and E 2 -5-136 are formed from (−)-and (+)-PCB 136, respectively (Wu et al. 2011) . Atropisomers (4-136) were separated on a Cyclosil-B capillary column (CB column, 30 m× 0.25 mm ID×0.25 μm film thickness; Agilent, Santa Clara, CA, USA). E 1 -4-136 and E 2 -4-136 are formed from (−)-and (+)-PCB 136, respectively (Wu et al. 2011) . The atropisomers of 4,5-136 could not be separated on either enantioselective column. The temperature program for the separation of the PCB and HO-PCB atropisomers was as follows: 15°C/min from 50 to 145°C (160), hold for 410 min (360), 15°C/min to 200°C, and hold for 10 min on the CD (CB) column. The injector and detector temperatures were kept at 250°C. The flow rate of the carrier gas (helium) was 3 mL/min. The enantiomeric fraction (EF) values for PCB 136, 5-136, and 4-136 were determined as EF=area E 2 /(area E 1 +area E 2 ).
Quality assurance and quality control
The 63 Ni-μECDs used for the analysis of PCB 136 and its metabolites were linear up to concentrations of 1000 ng/mL for all analytes investigated (R 2 >0.999). The recoveries of PCB 117 and 4-159 were 94±2 % (range 86 to 99 %) and 93±8 % (range 84 to 101 %), respectively. The limits of detection for PCB 136, and 4, 2.8, 4.3, and 1.7 ng, respectively (n=5) . The resolution (Rs) of PCB 136, 5-136, and 4-136 atropisomers were 0.882 (CD column), 0.737 (CD column), and 0.667 (CB column), respectively. The EF values for the racemic standards of PCB 136, 5-136, and 4-136 on the respective enantioselective column were 0.520 ± 0.021, 0.493 ± 0.002, and 0.514 ± 0.029, respectively.
Statistical analysis
The data are presented as the mean±SD (standard deviation). Differences in metabolites profiles, percentage change relative to incubation with glutathione or NAC, EF values of PCB 136, 5-136, and 4-136 were tested with two-sample, twotailed Student's t test. Comparisons were considered to be significant for p<0.05.
Results
Effect of glutathione on microsomal PCB 136 metabolism
Glutathione is an important cellular nucleophile that readily reacts with reactive PCB metabolites, such as PCB epoxides formed by P450 enzymes. Approximately 62 to 65 % of PCB 136 (5 μM, 10 nmol) were recovered as HO-PCB 136 metabolites after a 5-min incubation time from microsomal incubations containing 0-10 mM glutathione (Table 1) . Mass balances ranged from 96-107 %. The meta hydroxylated metabolites, 5-136, was the major metabolite in all incubations (88 to 96 % of the sum of HO-PCBs (ΣHO-PCBs)), independent of the glutathione concentration. In addition, the para hydroxylated metabolite, 4-136, and a vicinal dihydroxylated metabolite, 4,5-136, were detected as minor metabolites with >3 % of the ΣHO-PCBs. No 1,2-shift product was detected in any microsomal incubation. Levels of 4,5-136 increased compared to incubations without glutathione with increasing glutathione concentrations, whereas levels of unmetabolized PCB 136 as well as levels of 5-136 and 4-136 were essentially not affected be the presence of glutathione (Fig. 1b) . As a result, the HO-PCB metabolite profiles changed significantly in incubations at glutathione concentrations ≥0.1 mM (Table 1) .
NAC effect on PCB 136 metabolism
NAC is a precursor of glutathione and an important ROS scavenger of clinical interest. We therefore investigated the effect of NAC on the metabolism of PCB 136. Overall, the effects of NAC co-treatment on PCB 136 metabolism were comparable to the effects seen with glutathione, with 62 to 67 % of PCB 136 recovered as HO-PCB 136 metabolites from microsomal incubations containing 0-10 mM NAC (Table 1) . Mass balances ranged from 99 to 111 %. Three metabolites, 5-136, 4-136, and 4,5-136, were observed, with 5-136 being the major metabolite (>87 % of the ΣHO-PCBs). The 1,2 shift product was not detected under any of the conditions investigated. As with experiments using glutathione as antioxidant, levels of 4,5-136 increased with increasing concentration of NAC (Fig. 1c) , with 12 % of the ΣHO-PCBs being 4,5-136 at 10 mM NAC. At the same time, levels of PCB 136, 5-136, and 4-136 were not altered in the presence of NAC. The HO-PCB 136 metabolite profiles, expressed as percent of ΣHO-PCBs, were significantly different from the metabolite profile observed in incubations without NAC at NAC concentrations >1 mM due to the higher levels of 4,5-136 (Table 1) .
Effect of glutathione and NAC on the atropisomeric enrichment of PCB 136 and its metabolites
The direction and extent of the atropisomeric enrichment of PCB 136 and its two HO-PCB metabolites was determined using atropselective gas chromatography to determine if glutathione and NAC co-treatment affected the atropselectivity of PCB 136 metabolism. (−)-PCB 136 was enriched in all incubations, with EF values in the range of 0.43 to 0.47 (Fig. 2) . Moreover, both HO-PCB metabolites displayed considerable atropisomeric enrichment. The second eluting atropisomer of 5-136 (E 2 -5-136) and the first eluting atropisomer of 4-136 (E 1 -4-136) were enriched in all incubations. Co-treatment with glutathione or NAC (0 to 10 mM) did not affect the direction or extent of the atropisomeric enrichment of PCB 136 or its two HO-PCB metabolites.
Discussion
The microsomal metabolism observed in the present study is consistent with earlier in vitro studies using recombinant CYP2B1 enzyme (Lu et al. 2013) , rat liver microsomes (Wu et al. 2011) , and precision-cut rat liver tissue slices (Wu et al. 2013b ) from rats pretreated with phenobarbital, an inducer of hepatic CYP2B enzymes. Briefly, 5-136 was the major metabolite formed by CYP2B enzymes in these in vitro systems, whereas 4-136 and 4,5-136 were only minor metabolites. Both 5-136 and 4-136 were further metabolized by CYP2B enzymes to 4,5-136, a catechol metabolite of PCB 136 (Waller et al. 1999 ). While 5-136 was the major metabolite in this and other studies (Wu et al. 2011 (Wu et al. , 2013b , it is important to emphasize that the HO-PCB metabolite profile depended on the P450 isoform composition (Wu et al. 2011 ) of the respective in vitro model and, in addition, was highly species dependent (Ohta et al. 2005; Sundström and Jansson 1975; Wu et al. 2014) . Moreover, metabolite profiles can significantly differ from in vivo studies due to biotransformation and transport processes that are not present in in vitro assays. Growing experimental evidence suggests that these OH-PCB metabolites themselves are developmental neurotoxicants (Kodavanti et al. 2003; Niknam et al. 2013; Pessah et al. 2006) . The presence of physiologically relevant concentrations of glutathione significantly increased the levels of 4,5-136, with 4,5-136 representing over 10 % of the ΣHO-PCBs at 10 mM glutathione. A similar effect on 4,5-136 levels was observed in experiments using NAC. Several animal studies demonstrate that PCB catechol metabolites, such as 3′,4′-dihydroxy-4-chlorobiphenyl and 4,5-136, are efficiently eliminated, most likely as the corresponding sulfate or glucuronide conjugates (Birnbaum 1983; Dhakal et al. 2014; Haraguchi et al. 2004; Wu et al. 2015) . It is therefore possible that reduced hepatic glutathione stores are associated with a decreased formation and elimination of 4,5-136 conjugates, and additional studies are needed to investigate whether reduced glutathione levels, e.g., due to a disease (Pastore et al. 2003) , alter the phase II metabolism of PCB 136 and other PCB congeners in vivo.
Neither the extent of PCB 136 metabolism nor the levels of 5-136 and 4-136 in the microsomal incubations were affected by the presence of glutathione or NAC. Therefore, it seems unlikely that the increase in 4,5-136 levels observed in our study was due to an antioxidant-mediated increase in PCB and/or HO-PCB metabolism rates because to the best of our knowledge there is no evidence that the redox environment regulates the activity of P450 enzymes involved in PCB metabolism. However, this possibility cannot be completely dismissed because rat CYP2B enzymes involved in the metabolism of PCB 136 (Lu et al. 2013; Warner et al. 2009 ) contain several cysteine residues. Moreover, several studies have shown that human CYP3A4 activity is increased in the presence of glutathione, but not other thiol containing antioxidants (Gillam et al. 1993; Kim and Kim 1998) due to an allosteric effect of glutathione on CYP3A4 (Davydov et al. 2008) .
Since PCB 136 and structurally related PCBs (e.g., PCB 84) enantioselectively affect cellular targets implicated in PCB developmental neurotoxicity (Lehmler et al. 2005; Pessah et al. 2009; Yang et al. 2014) , the enantiomeric fractions of PCB 136 and its OH-PCB metabolites were measured for each microsomal incubation. The goal was to determine if the presence of varying concentrations of thiol antioxidants alters the enantioselectivity of the P450 enzyme-mediated oxidation of PCB 136. We observed considerable atropisomeric enrichment of (−)-PCB 136, E 2 -5-136 and E 1 -4-136, which is consistent with our earlier microsomal metabolism studies using rat liver microsomes (Wu et al. 2011) . Moreover, the enrichment of (-)-PCB 136 was in agreement with an in vivo disposition study in rats (Kania-Korwel et al. 2008) . However, the EF values of PCB 136 and its HO-PCB metabolites in the microsomal incubations were similar across all glutathione and NAC concentrations investigated. Therefore, it seems unlikely that differences in the glutathione levels in metabolically active tissues [e.g., due to co-exposures to xenobiotics, including certain PCB congeners (Lai et al. 2010) , or diseases associated with a reduced levels of glutathione (Pastore et al. 2003) ] modulate the levels of neurotoxic PCB and/or OH-PCB enantiomers in target tissues and, thus, affect PCB developmental neurotoxicity in vivo.
Reactive arene oxide intermediates have been implicated in the covalent binding of PCB 136 metabolites to microsomal protein in a study with pooled human liver microsomes (Schnellmann et al. 1983 ). However, the trapping of arene oxide intermediates by glutathione or NAC is expected to affect levels of mono-and not di-hydroxylated PCB 136 metabolites, which was not observed in the present study. Moreover, the chemical reaction of an arene oxides derived from PCB 52 (2,2′,5,5′-tetrachlorobiphenyl) with thiol oxidants appeared to be relatively slow (Preston et al. 1984) and likely did not occur to a significant extent during the short incubation time used in the present study. Alternatively, a couple of studies demonstrated that reactive quinone metabolites are responsible for the binding of PCBs (Hesse et al. 1978) and hexachlorobenzene (van Ommen et al. 1986 ) to microsomal proteins. In both studies, antioxidants prevented the binding of the quinone intermediates to microsomal proteins by reducing the quinone back to a hydroquinone metabolite or by forming covalent adducts. Similarly, it is possible that thiol antioxidants alter the balance of PCB catechol vs. PCB quinone metabolites by preventing the oxidation of 4,5-136 to the corresponding PCB quinone or by reducing the PCB quinones back to 4,5-136. However, further studies of the chemistry of ortho PCB quinones, such as the ortho quinone formed from 4,5-136, are needed to confirm this hypothesis because conflicting evidence suggests that thiol antioxidants, such as glutathione, do not act as a reducing agent in the presence of chlorinated para quinones but forms covalent adducts (Song et al. 2009 (Song et al. , 2013 van Ommen et al. 1986 ).
Conclusions
The present study demonstrates that thiol antioxidants do not alter the stereoselectivity of the metabolism of PCB 136. However, the antioxidant-dependent increase in the levels of the catechol metabolite 4,5-136 suggests that, similar to other chlorinated aromatic compounds, a reactive PCB 136 quinone may be formed in microsomal preparations, and that the balance of catechol vs. quinone metabolite may depend of the cellular glutathione status. This observation may have important toxicological implications because PCB quinones play in important role in the toxicity of PCBs. Further studies are therefore needed to elucidate how thiol antioxidants alter PCB metabolite profiles in microsomal incubations and if hepatic antioxidant levels also affect PCB metabolite profiles and toxicity in vivo.
